FDA releases artificial intelligence/machine learning action plan

FDA

12 January 2021 - Today, the U.S. FDA released the agency’s first artificial intelligence/machine learning-based software as a Medical Device Action Plan. 

This action plan describes a multi-pronged approach to advance the Agency’s oversight of artificial intelligence/machine learning-based medical software.

Read FDA press release

Michael Wonder

Posted by:

Michael Wonder